Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

CVRX


Fundamental

Company: CVRx Inc
Sector: Healthcare
Industry: Medical Devices
Country: USA
Exchange: Micro
Index: RUT
P/E: -
EPS (ttm): -2.04
Insider Own: 44.72%
Shs Outstand: 26.31M
Perf Week: 0.27%
Market Cap: 206.03M
Forward P/E: -
EPS next Y: -1.87
Insider Trans: -0.26%
Shs Float: 14.61M
Perf Month: -17.13%
Enterprise Value: 180.82M
PEG: -
EPS next Q: -0.50
Inst Own: 30.94%
Short Float: 11.42%
Perf Quarter: 7.76%
Income: -53.31M
P/S: 3.64
EPS this Y: 3.08%
Inst Trans: 5.82%
Short Ratio: 5.32
Perf Half Y: -26.40%
Sales: 56.65M
P/B: 5.02
EPS next Y Percentage: 5.49%
ROA: -44.76%
Short Interest: 1.67M
Perf YTD: 5.63%
Book/sh: 1.49
P/C: 2.72
EPS next 5Y: 6.64%
ROE: -96.59%
52W High: 11.30 -33.63%
Perf Year: -3.72%
Cash/sh: 2.76
P/FCF: -
EPS past 3/5Y: -0.43% -22.44%
ROIC: -59.58%
52W Low: 4.30 74.45%
Perf 3Y: -40.52%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: 36.11% 56.40%
Gross Margin: 83.99%
Volatility W: 9.22%
Volatility M: 8.84%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 3.19
EPS Y/Y TTM: 24.27%
Oper. Margin: -90.49%
ATR (14): 0.62
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 6.72
Sales Y/Y TTM: 10.45%
Profit Margin: -94.10%
RSI (14): 46.82
Recom: 1.57
Dividend Gr. 3/5Y: - -
Current Ratio: 7.63
EPS Q/Q: -5.64%
SMA20: -0.76%
Beta: 0.87
Target Price: 11.17
Payout: -
Debt/Eq: 1.28
Sales Q/Q: 4.45%
SMA50: -6.78%
Rel Volume: 0.51
Prev Close: 7.80
Employees: 223
LT Debt/Eq: 1.28
Earnings: May 11 AMC
SMA200: -6.60%
Avg Volume: 313.46K
Price: 7.50
IPO: Jun 30, 2021
Option/Short: Yes / Yes
EPS/Sales Surpr.: -4.88% 1.56%
Trades:
Volume: 160,487
Change: -3.78%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z
William Blair cuts CVRx stock rating on salesforce issues - Investing.com somewhat bearish
CVRX

Summary: CVRx Inc (NASDAQ:CVRX) was downgraded by William Blair from Outperform to Market Perform due to first-quarter sales falling short of expectations, leading to lower revenue guidance and internal salesforce issues impacting performance.

Full article
2024-05-01T17:35:02Z